Paper24459205
An update on the biology of sphingosine 1-phosphate receptors.
Blaho VA and 1 other. J Lipid Res, 2014. Cited by 457 papers, by iCite.
Cite this record
ConductScience Library. An update on the biology of sphingosine 1-phosphate receptors. Papers, record 24459205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24459205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Lysophospholipids | Major topic |
| Neoplasm Proteins | Major topic |
| Neoplasms | Major topic |
| Receptors, Lysosphingolipid | Major topic |
| Signal Transduction | Major topic |
| Sphingosine | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL070694 | NHLBI NIH HHS | United States | P01HL070694 | PubMed and NIH | NIH RePORTER |
| R01 HL067330 | NHLBI NIH HHS | United States | R01HL067330 | PubMed and NIH | NIH RePORTER |
| R01 HL089934 | NHLBI NIH HHS | United States | R01HL089934 | PubMed and NIH | NIH RePORTER |
| R37 HL067330 | NHLBI NIH HHS | United States | R01HL067330 | PubMed and NIH | NIH RePORTER |
| R37HL067330 | NIH | NIH RePORTER |
References175
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23419711 | Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. | Lab Invest | 2013 | https://conductscience.org/library/papers/23419711 | PubMed |
| 2 | 23285242 | The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat. | PLoS One | 2012 | https://conductscience.org/library/papers/23285242 | PubMed |
| 3 | 21527515 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. | Blood | 2011 | https://conductscience.org/library/papers/21527515 | PubMed |
| 4 | 16498448 | Neutrophils and immunity: challenges and opportunities. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16498448 | PubMed |
| 5 | 9726979 | Molecular cloning and functional characterization of murine sphingosine kinase. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9726979 | PubMed |
| 6 | 23263181 | Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. | Nature | 2013 | https://conductscience.org/library/papers/23263181 | PubMed |
| 7 | 24076635 | Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. | Nat Immunol | 2013 | https://conductscience.org/library/papers/24076635 | PubMed |
| 8 | 22588662 | Sphingosine 1-phosphate-primed astrocytes enhance differentiation of neuronal progenitor cells. | J Neurosci Res | 2012 | https://conductscience.org/library/papers/22588662 | PubMed |
| 9 | 23253209 | Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. | Allergy | 2013 | https://conductscience.org/library/papers/23253209 | PubMed |
| 10 | 22751847 | Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. | Arch Neurol | 2012 | https://conductscience.org/library/papers/22751847 | PubMed |
| 11 | 23649711 | Fingolimod modulates peripheral effector and regulatory T cells in MS patients. | J Neuroimmune Pharmacol | 2013 | https://conductscience.org/library/papers/23649711 | PubMed |
| 12 | 22019019 | Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking sphingosine 1-phosphate receptor 2. | Epilepsy Behav | 2011 | https://conductscience.org/library/papers/22019019 | PubMed |
| 13 | 22639011 | Fingolimod--a sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes. | Glia | 2012 | https://conductscience.org/library/papers/22639011 | PubMed |
| 14 | 19664713 | Structure and function of the blood-brain barrier. | Neurobiol Dis | 2010 | https://conductscience.org/library/papers/19664713 | PubMed |
| 15 | 9660876 | Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9660876 | PubMed |
| 16 | 21520239 | Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. | Ann Neurol | 2011 | https://conductscience.org/library/papers/21520239 | PubMed |
| 17 | 17885683 | Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17885683 | PubMed |
| 18 | 22615252 | The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium. | Infect Immun | 2012 | https://conductscience.org/library/papers/22615252 | PubMed |
| 19 | 24259678 | Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24259678 | PubMed |
| 20 | 20463015 | CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20463015 | PubMed |
Cited by291
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 457 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42864953 | Etrasimod reduces circulating and mucosal inflammatory lymphocyte populations and alters innate immune and non-immune cell signatures in intestinal mucosa: ELEVATE UC phase 3 clinical data. | J Crohns Colitis | 2026 | https://conductscience.org/library/papers/42864953 | PubMed |
| 42780639 | Effects of sphingosine-1-phosphate receptor modulators on remyelination in multiple sclerosis: evidence from in vitro experiments, animal models and human studies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780639 | PubMed |
| 42711443 | Integrative multi-omics analysis reveals lipid/metabolite dysregulation and temporal decoupling in disease progression. | Sci Rep | 2026 | https://conductscience.org/library/papers/42711443 | PubMed |
| 42560404 | Sphingolipids and Atherosclerosis. | Curr Atheroscler Rep | 2026 | https://conductscience.org/library/papers/42560404 | PubMed |
| 42486932 | Identifying lipid-protein interactomes with functional lipid probes. | Nat Protoc | 2026 | https://conductscience.org/library/papers/42486932 | PubMed |
| 42314164 | Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer. | Cancer Res | 2026 | https://conductscience.org/library/papers/42314164 | PubMed |
| 42310690 | Higher disease reactivation risk in women after fingolimod withdrawal. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42310690 | PubMed |
| 42278317 | From Lysosomal Storage to Neurodegeneration: Sphingolipid Signaling as a Driver of CNS Pathology and Biomarker Strategy in Neuronopathic Gaucher Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278317 | PubMed |
| 42266796 | Sphingolipid Signaling in Vascular Smooth Muscle Cells during Development and Diseases. | JMA J | 2026 | https://conductscience.org/library/papers/42266796 | PubMed |
| 42183212 | Natural killer T cells in intracerebral hemorrhage: phase-dependent immune responses and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183212 | PubMed |
| 42122966 | Higher Plasma Sphingosine-1-Phosphate Levels in Type 2 Diabetic Patients Have a Non-Linear Relationship with the Disease Prognostic Indices and Microvascular Complications: A Cross-Sectional Saudi Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42122966 | PubMed |
| 42108841 | Sphingosine-1-Phosphate as an Immune-Metabolic Biomarker in Neurodegenerative Diseases. | J Clin Neurol | 2026 | https://conductscience.org/library/papers/42108841 | PubMed |
| 42092170 | Using an integrated omics approach to uncover the mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN). | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42092170 | PubMed |
| 42034830 | Enhancement of a nuclear factor of activated T cells (NFAT) reporter for the study of G protein-coupled receptors. | Commun Biol | 2026 | https://conductscience.org/library/papers/42034830 | PubMed |
| 41994486 | The sphingosine-1-phosphate pathway is differentially activated in human gestational tissues. | J Endocr Soc | 2026 | https://conductscience.org/library/papers/41994486 | PubMed |
| 41905664 | Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity. | J Lipid Res | 2026 | https://conductscience.org/library/papers/41905664 | PubMed |
| 41756427 | Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abuse. | Res Sq | 2026 | https://conductscience.org/library/papers/41756427 | PubMed |
| 41573960 | An Integrated Method for Profiling Lipid-Protein Interactions Using Multifunctional Lipid Probes. | bioRxiv | 2026 | https://conductscience.org/library/papers/41573960 | PubMed |
| 41537371 | The expanding role of Nogo-B in hypertension: linking kidney physiology, endothelial function and inflammation. | J Hypertens | 2026 | https://conductscience.org/library/papers/41537371 | PubMed |
| 41496670 | The multifaceted significance of phosphoinositides in endocytic trafficking. | FEBS Lett | 2026 | https://conductscience.org/library/papers/41496670 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| S1PR1 | 1901 | PubTator's text mining | https://conductscience.org/library/genes/1901 | NCBI Gene |
| S1PR2 | 9294 | PubTator's text mining | https://conductscience.org/library/genes/9294 | NCBI Gene |
| S1PR3 | 1903 | PubTator's text mining | https://conductscience.org/library/genes/1903 | NCBI Gene |
| S1PR4 | 8698 | PubTator's text mining | https://conductscience.org/library/genes/8698 | NCBI Gene |
| S1PR5 | 53637 | PubTator's text mining | https://conductscience.org/library/genes/53637 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24459205
GET https://conductscience.org/api/papers/v1/24459205/references?page=2